Advertisement

PentaVision

Optometric Management

Article

LEADING OFF: Also Notable

Optometric Management November 1, 2023 Vol 58, Issue Nov/Dec 2023 Page(s): 45, 47
  • Bruder Healthcare added the on-the-go, single-use moist heat eye mask, Eyedration by Bruder, for those who have dry, tired eyes. The mask, which starts heating once opened and exposed to the air, generates therapeutic moist heat to help maintain tear production, according to a press release. Ordering is open now for eye care professionals at www.Bruder.com/pro , with delivery in November 2023. Patient ordering will be available by December 2023 at www.Bruder.com .
  • The Contact Lens Institute (CLI) published “The Culture Calculation: Data-Backed Behaviors for Contact Lens Success” in collaboration with The Vision Council to help eye care practices enhance their contact lens cultures, in turn increasing patient satisfaction and practice business outcomes, according to a press release. As part of the CLI’s “See Tomorrow” research series, the 19-page report blends new quantitative research with insights and recommendations from optometrists, opticians, and technicians. For more information, visit contactlensinstitute.org .
  • DryEye Rescue and Sunnie Natural entered into an exclusive partnership to launch a range of all-natural, plant-based eye drops. The products are multi-dose formulations, made without preservatives, and are “safe for everyday use, ensuring long-lasting support for those experiencing redness, dryness, or strains associated with digital eye fatigue,” according to the press release. For more information, visit www.sunnienatural.com .
  • EssilorLuxottica launched Helix, a new division of the company focused on helping eye care practitioners leverage modern technology to improve the efficiency of their practices. Specifically, Helix will help doctors to reduce the amount of tech and administrative burdens associated with practice by harnessing the power of EssilorLuxottica’s US digital solutions, including VisionWeb, CLX, 4PatientCare, and Revenue Cycle Management, according to a press release. For more information, visit www.helixsolution.com .
  • Harrow changed its corporate name from “Harrow Health, Inc.” to “Harrow, Inc.” to align with its current five-year strategic plan, which includes an exclusive focus on eye care pharmaceuticals, according to a Harrow press release.
  • Indiana University School of Optometry Emeritus Professor David Goss, OD, PhD, has had his book on the history of optometry published. The book, “From Spectacle Making Trade to Scholarly Profession: A History of Optometry in the United States,” is the first comprehensive book on optometry history in more than 50 years, according to its publisher Pacific University Press.
  • IDOC’s The Connection 2024 will take place at Kalahari Resorts and Conventions in Austin, Texas, from Feb. 15 to Feb. 18, 2024. The three-day event will offer attendees over 30 hours of CE courses, a first-hand look at IDOC’s Bookkeeping and Marketing Services and growing lab, Three Rivers Optical, in addition to more than 60 vendors. Register at idoc.swoogo.com/connection2024 .
  • Johnson & Johnson Vision enlisted professional photographer/director and New York Times best-selling author Kate T. Parker for “Vision Made Possible,” a global effort to raise awareness and ignite conversation about the importance of eye health across all ages and stages of vision. Ms. Parker, who’s known for her modern, highly stylized approach to visual art, will capture the real-life stories of patients for the effort. For more information, visit https://www.jjvision.com/ .
  • Meta and EssilorLuxottica have introduced a new set of smart glasses, the Ray-Ban Meta. The new collection of smart glasses offer live streaming and Meta AI built-in, a camera, and audio and microphone systems paired with an app and charging case. The Ray-Ban Meta smart glasses start at a suggested entry price of $299 and is available to purchase at Ray-Ban stores, Ray-Ban.com , Meta.com , as well as select EssilorLuxottica retail stores.
  • The Vision Council released a new report delving into consumer awareness, interest, and sentiment toward smart eyewear products. The report, “Focused inSights Smart Eyewear 2023,” found that more than a third of Americans intend to purchase tech eyewear within the year, with men ages 18 to 44, those in urban communities, and early adopters of technology especially likely to purchase. The full report is available in The Vision Council’s Research Download Center as a complimentary download for members of The Vision Council, with a paid option for non-members.
  • Vision Expo East will have its 2025 conference held in Orlando, Fla., at the Orange County Convention Center (OCCC) February 19–22, 2025. Vision Expo East’s final show in its current home of New York City’s Javits Center will occur March 14–17, 2024.
  • Visioneering Technologies, Inc., presented the one-year interim retrospective data of its PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial, or PROTECT, randomized control trial at the American Academy of Optometry’s annual meeting. The data showed slowing of myopia progression, which confirms that the NaturalVue contact lens effectively manages eye growth and refractive error change among progressing myopic children. Additional details are coming in January 2024, according to a press release.
  • Vitaris launched a national direct-to-consumer campaign for the dry eye nasal spray TYRVAYA (varenicline solution). The campaign, called “It’s Not Another Drop,” is directed to both consumers and eye care professionals, and aims to encourage patients to discuss the treatment with their eye care professional.
  • Zeiss Medical Technology and Boehringer Ingelheim announced a long-term strategic collaboration to create predictive analytics to enable the early detection of eye diseases and more personalized treatments to prevent vision loss for people who have serious eye diseases, according to a press release. Specifically, the two entities will focus on identifying markers of early stages of retinal diseases by leveraging Zeiss Medical Technology’s cloud-connected devices and artificial intelligence-assisted analysis of massive image data sets.

What to Read Next